[go: up one dir, main page]

CN108272903A - A kind of prescription for losing weight and its application process - Google Patents

A kind of prescription for losing weight and its application process Download PDF

Info

Publication number
CN108272903A
CN108272903A CN201810213630.5A CN201810213630A CN108272903A CN 108272903 A CN108272903 A CN 108272903A CN 201810213630 A CN201810213630 A CN 201810213630A CN 108272903 A CN108272903 A CN 108272903A
Authority
CN
China
Prior art keywords
menthol
linoleic acid
conjugated linoleic
carnitine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810213630.5A
Other languages
Chinese (zh)
Inventor
杨丹凤
李曦
张莉
张永强
郭展
潘文斌
钱凯强
丁鹏飞
王锐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Environmental Medicine and Operational Medicine Institute of Military Medicine Institute of Academy of Military Sciences
Original Assignee
Environmental Medicine and Operational Medicine Institute of Military Medicine Institute of Academy of Military Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Environmental Medicine and Operational Medicine Institute of Military Medicine Institute of Academy of Military Sciences filed Critical Environmental Medicine and Operational Medicine Institute of Military Medicine Institute of Academy of Military Sciences
Priority to CN201810213630.5A priority Critical patent/CN108272903A/en
Publication of CN108272903A publication Critical patent/CN108272903A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明属于保健品技术领域,涉及一种减肥配方及其应用方法。所述减肥配方包括以下质量百分比的组分:辣椒素酯0.1~80%;薄荷醇1~80%;左旋肉碱1~60%;共轭亚油酸1~80%。所述应用方法为:按照配方质量百分比称取各组分,将辣椒素酯和薄荷醇溶于油性溶剂中,施用于生命体,然后将左旋肉碱和共轭亚油酸溶于水中,继续施用于生命体。The invention belongs to the technical field of health products, and relates to a slimming formula and an application method thereof. The weight loss formula comprises the following components in mass percentage: 0.1-80% of capsaicinate; 1-80% of menthol; 1-60% of L-carnitine; 1-80% of conjugated linoleic acid. The application method is as follows: each component is weighed according to the mass percentage of the formula, capsaicin ester and menthol are dissolved in an oily solvent, and applied to a living body, then L-carnitine and conjugated linoleic acid are dissolved in water, and continue applied to living organisms.

Description

一种减肥配方及其应用方法A kind of weight loss formula and its application method

技术领域technical field

本发明属于保健品技术领域,涉及一种减肥配方及其应用方法。The invention belongs to the technical field of health products, and relates to a slimming formula and an application method thereof.

背景技术Background technique

肥胖病是能量摄入超过能量消耗而导致体内脂肪积聚过多,且达到危害程度的一种慢性代谢性疾病。随着物质的丰富,生活水平的提高,肥胖症日益变成人们越来越关注也越来越头疼的问题,日益成为威胁人类健康的现代社会流行的慢性病。所谓肥胖是万症之源,肥胖除了影响身心健康外,它还会影响消化系统功能、内分泌系统功能、增加癌症发生的危险性和心血管疾病的危险等等。很多人通过减少摄入食物来减肥,虽然短期成效好,但是对人体的健康会产生不好后果,也影响正常生活工作,且一旦恢复正常饮食又易反弹。因此现如今市面上出现琳琅满目的减肥产品,包括减肥药和减肥保健食品,减肥药的减肥效果虽然较明显,但普遍存在着副作用大,药物依赖性强的缺点。而减肥保健食品虽然副作用和依赖性较小,但减肥效果多不明显。因此,开发出治疗和预防肥胖的新药物或保健食品具有非常重要的意义。Obesity is a chronic metabolic disease in which energy intake exceeds energy expenditure, resulting in excessive accumulation of body fat, which has reached a harmful level. With the abundance of materials and the improvement of living standards, obesity has increasingly become a problem that people are paying more and more attention to and headaches, and has increasingly become a chronic disease that threatens human health in modern society. The so-called obesity is the source of all diseases. In addition to affecting physical and mental health, obesity can also affect the function of the digestive system, endocrine system, increase the risk of cancer and the risk of cardiovascular disease, etc. Many people lose weight by reducing food intake. Although the short-term effect is good, it will have adverse consequences on human health and affect normal life and work. Once the normal diet is restored, it is easy to rebound. Therefore appear a dazzling array of weight-loss products on the market now, comprise weight-loss medicine and weight-loss health food, although the weight-loss effect of weight-loss medicine is more obvious, ubiquitous side effect is big, the shortcoming of strong drug dependence. And although the side effects and dependence of weight-loss health food are small, the effect of weight loss is not obvious. Therefore, it is of great significance to develop new drugs or health foods for the treatment and prevention of obesity.

发明内容Contents of the invention

本发明针对现有技术中存在的问题,提供一种以辣椒素酯、薄荷醇、左旋肉碱和共轭亚油酸作为减肥有效成分的配方,该配方减肥效果显著,且无副作用。Aiming at the problems in the prior art, the present invention provides a formula using capsaicin, menthol, L-carnitine and conjugated linoleic acid as active ingredients for weight loss. The formula has significant weight loss effect and no side effects.

本发明的一个目的可通过下列技术方案来实现:一种减肥配方,所述配方包括以下质量百分比的组分:辣椒素酯0.1~80%;薄荷醇1~80%;左旋肉碱1~60%;共轭亚油酸1~80%。An object of the present invention can be achieved through the following technical solutions: a weight loss formula, said formula comprising the following components in mass percent: capsaicin ester 0.1-80%; menthol 1-80%; L-carnitine 1-60% %; Conjugated linoleic acid 1-80%.

辣椒素酯是来源于辣椒中的天然化合物,可通过激活体内瞬时感受器电位离子通道TRPV1和TRPA1,增强肾上腺儿茶酚胺的分泌作用,具有促进能量代谢、抑制肥胖、无毒性的特点,其在减肥临床应用方面具有很大的优势。薄荷醇是常用的调味品和添加剂,也是TRPM8和TRPA1的天然激动剂,其可以激活TRPM8和TRPA1,通过细胞内[Ca2+]变化影响产热蛋白UCP1及其相关分子的表达。辣椒素酯和薄荷醇均可激活体内棕色脂肪产热功能并促进白色脂肪棕色化,增加线粒体有氧呼吸代谢产热量,导致机体代谢产热量增加,消耗脂肪从而抵抗肥胖。Capsaicin ester is a natural compound derived from peppers, which can enhance the secretion of adrenal catecholamines by activating the transient receptor potential ion channels TRPV1 and TRPA1 in the body. It has the characteristics of promoting energy metabolism, inhibiting obesity, and non-toxicity. It is clinically used in weight loss has great advantages. Menthol is a commonly used condiment and additive, and it is also a natural agonist of TRPM8 and TRPA1, which can activate TRPM8 and TRPA1, and affect the expression of the thermogenic protein UCP1 and its related molecules through changes in intracellular [Ca 2+ ]. Both capsaicinate and menthol can activate the thermogenic function of brown fat in the body and promote the browning of white fat, increase the heat production of mitochondrial aerobic respiration, lead to an increase in the body's metabolic heat production, and consume fat to resist obesity.

左旋肉碱也叫L-肉碱或维生素BT,是一种促使脂肪转化为能量的类氨基酸。左旋肉碱的主要生理功能是辅助脂肪酸进入线粒体,参与有氧呼吸,进而增加脂肪在有氧呼吸所消耗原料中的比例,促进脂肪转化成能量。服用左旋肉碱能够在减少身体脂肪、降低体重的同时,不减少水分和肌肉,2003年左旋肉碱被国际肥胖健康组织认定为最安全无副作用的减肥营养补充品。共轭亚油酸是一类含有共轭双键的亚油酸异构体,普遍存在于反刍动物性食品中,如牛奶、奶酪、牛肉、羊肉及脂肪等。共轭亚油酸可改善脂肪代谢,通过减少体内脂肪的积累并促进瘦肌肉生长从而改变身体成分,提高健康水平,其对肥胖的预防也具有非常显著的积极作用。L-carnitine, also known as L-carnitine or vitamin BT, is an amino acid that promotes the conversion of fat into energy. The main physiological function of L-carnitine is to assist fatty acids to enter the mitochondria and participate in aerobic respiration, thereby increasing the proportion of fat in the raw materials consumed by aerobic respiration, and promoting the conversion of fat into energy. Taking L-carnitine can reduce body fat and weight without reducing water and muscle. In 2003, L-carnitine was recognized by the International Obesity Health Organization as the safest weight loss nutritional supplement without side effects. Conjugated linoleic acid is a type of linoleic acid isomers containing conjugated double bonds, which are commonly found in ruminant foods, such as milk, cheese, beef, mutton and fat. Conjugated linoleic acid can improve fat metabolism, change body composition and improve health by reducing body fat accumulation and promoting lean muscle growth. It also has a very significant positive effect on obesity prevention.

然而,单独应用辣椒素酯或薄荷醇,由于其不影响线粒体消耗葡萄糖和脂肪的比例,对脂肪消耗的影响有限;而单独应用左旋肉碱,虽可以提高线粒体脂肪消耗的比例,却并不能增加能量消耗的总量,因而其减肥效果通常不佳,常需要复合有氧运动等增加能量消耗的因素方可实现。因此,本发明在应用辣椒素酯和薄荷醇增加机体能量消耗的同时,辅以左旋肉碱和共轭亚油酸,提高脂肪消耗的比例,并促进肌肉的增长,实现减脂增肌的效果。However, the application of capsaicinoid or menthol alone has a limited effect on fat consumption because it does not affect the proportion of glucose and fat consumed by mitochondria; while the application of L-carnitine alone can increase the proportion of mitochondrial fat consumption, but it does not increase The total amount of energy consumption, so its weight loss effect is usually not good, often need compound aerobic exercise and other factors that increase energy consumption to achieve. Therefore, the present invention uses capsaicin ester and menthol to increase the energy consumption of the body, supplemented with L-carnitine and conjugated linoleic acid to increase the proportion of fat consumption, and promote muscle growth, so as to achieve the effect of reducing fat and increasing muscle .

作为优选,所述配方包括以下质量百分比的组分:辣椒素酯0.1~40%;薄荷醇10~50%;左旋肉碱10~50%;共轭亚油酸15~55%。Preferably, the formula includes the following components in mass percentage: 0.1-40% capsaicinate; 10-50% menthol; 10-50% L-carnitine; 15-55% conjugated linoleic acid.

作为优选,所述配方包括以下质量百分比的组分:辣椒素酯0.1~10%;薄荷醇15~20%;左旋肉碱30~40%;共轭亚油酸30~40%。Preferably, the formula includes the following components in mass percentage: 0.1-10% capsaicinate; 15-20% menthol; 30-40% L-carnitine; 30-40% conjugated linoleic acid.

作为优选,所述配方包括以下质量百分比的组分:辣椒素酯0.3~0.5%;薄荷醇19~20%;左旋肉碱39~40%;共轭亚油酸39~40%。以上述质量百分比组分形成的减肥配方,为本发明的最优方案,减肥效果最佳。Preferably, the formula includes the following components in mass percentage: 0.3-0.5% capsaicinate; 19-20% menthol; 39-40% L-carnitine; 39-40% conjugated linoleic acid. The weight loss formula formed with the above mass percentage components is the optimal solution of the present invention, and has the best weight loss effect.

本发明的另一个目的可通过下列技术方案来实现:一种减肥配方的应用方法,所述应用方法为:按照配方质量百分比称取各组分,将辣椒素酯和薄荷醇溶于油性溶剂中,施用于生命体,然后将左旋肉碱和共轭亚油酸溶于水中,继续施用于生命体。Another object of the present invention can be achieved through the following technical solutions: a method of application of weight loss formula, said application method is: take each component according to formula mass percentage, capsaicinoid and menthol are dissolved in oily solvent , applied to the living body, and then L-carnitine and conjugated linoleic acid were dissolved in water and continued to be applied to the living body.

因辣椒素酯、薄荷醇和左旋肉碱、共轭亚油酸的溶解性不同,用同一种溶剂溶解势必会引起个别组分的溶解不均匀,从而影响配方效果。本发明先将辣椒素酯和薄荷醇溶于油性溶剂中,配制成一定比例的溶液,经口服进入生命体,再将左旋肉碱和共轭亚油酸溶于水中,进入生命体。其中所述油性溶剂可以为大豆油、花生油、玉米油等。辣椒素酯按照0.1~10mg/kg体重施用于生命体,具体数值根据生命体需要达到的减肥效果进行选择,剩余三种组分的施用量根据辣椒素酯的施用量确定。Due to the different solubility of capsaicin, menthol, L-carnitine, and conjugated linoleic acid, dissolving in the same solvent will inevitably cause uneven dissolution of individual components, thereby affecting the formula effect. In the invention, firstly, capsaicin ester and menthol are dissolved in an oily solvent, and prepared into a certain proportion solution, which is taken orally into the living body, and then L-carnitine and conjugated linoleic acid are dissolved in water to enter the living body. Wherein said oily solvent can be soybean oil, peanut oil, corn oil etc. The capsaicinoid is administered to the living body according to 0.1-10mg/kg body weight, and the specific value is selected according to the weight loss effect that the living body needs to achieve, and the dosage of the remaining three components is determined according to the dosage of the capsaicinoid.

本发明考虑到各种组分不同的溶解性能,采用不同溶剂溶解,分别施用于生命体,此外,也可以通过特殊处理工艺,如乳化、微胶囊化,将减肥配方各组分同时溶于油性溶剂或者水中,形成均一溶液施用于生命体。The present invention takes into account the different solubility properties of various components, uses different solvents to dissolve, and applies them to the living body respectively. In addition, various components of the weight loss formula can also be dissolved in the oily formula at the same time through special treatment processes, such as emulsification and microencapsulation. Solvent or water, form a uniform solution and apply it to living organisms.

本发明提供的减肥配方,通过辣椒素酯、薄荷醇、左旋肉碱和共轭亚油酸的协同促进作用,能够加速身体中脂肪的分解并转化为能量,同时抑制机体对脂肪和糖类的吸收,从而达到控制及减轻体重的目的。另外,本发明提供的减肥配方效果持久,对人体无任何毒副作用,不会反弹,能够有效促进减肥者的身体健康。The weight loss formula provided by the invention can accelerate the decomposition of fat in the body and convert it into energy through the synergistic promotion effect of capsaicin ester, menthol, L-carnitine and conjugated linoleic acid, and at the same time inhibit the body's reaction to fat and carbohydrates. Absorption, so as to achieve the purpose of weight control and weight loss. In addition, the slimming formula provided by the invention has a long-lasting effect, has no toxic and side effects on the human body, does not rebound, and can effectively promote the health of dieters.

具体实施方式Detailed ways

以下是本发明的具体实施例,对本发明的技术方案作进一步的描述,但本发明并不限于这些实施例。如果无特殊说明,本发明的实施例中所采用的原料均为本领域常用的原料,实施例中所采用的方法,均为本领域的常规方法。The following are specific examples of the present invention to further describe the technical solutions of the present invention, but the present invention is not limited to these examples. Unless otherwise specified, the raw materials used in the examples of the present invention are commonly used raw materials in the art, and the methods used in the examples are conventional methods in the art.

实施例1Example 1

本实施例的减肥配方为辣椒素酯600mg;薄荷醇150mg;左旋肉碱150mg;共轭亚油酸100mg。按照配方质量称取各组分,将辣椒素酯和薄荷醇溶于600ml大豆油中,待用,然后将左旋肉碱和共轭亚油酸溶于600ml水中,待用。The slimming formula of this embodiment is capsaicin ester 600 mg; menthol 150 mg; L-carnitine 150 mg; conjugated linoleic acid 100 mg. Weigh each component according to formula quality, dissolve capsaicinoid ester and menthol in 600ml soybean oil, stand-by, then dissolve L-carnitine and conjugated linoleic acid in 600ml water, stand-by.

实施例2Example 2

本实施例的减肥配方为辣椒素酯500mg;薄荷醇1.8g;左旋肉碱3.2g;共轭亚油酸4.5g。按照配方质量称取各组分,将辣椒素酯和薄荷醇溶于500ml大豆油中,待用,然后将左旋肉碱和共轭亚油酸溶于500ml水中,待用。The weight loss formula of this embodiment is capsaicin ester 500 mg; menthol 1.8 g; L-carnitine 3.2 g; conjugated linoleic acid 4.5 g. Weigh each component according to the formula quality, dissolve capsaicinoid ester and menthol in 500ml soybean oil, stand-by, then dissolve L-carnitine and conjugated linoleic acid in 500ml water, stand-by.

实施例3Example 3

本实施例的减肥配方为辣椒素酯100mg;薄荷醇5g;左旋肉碱10g;共轭亚油酸10g。按照配方质量称取各组分,将辣椒素酯和薄荷醇溶于100ml大豆油中,待用,然后将左旋肉碱和共轭亚油酸溶于100ml水中,待用。The weight loss formula of this embodiment is 100 mg of capsaicin ester; 5 g of menthol; 10 g of L-carnitine; and 10 g of conjugated linoleic acid. Weigh each component according to the formula quality, dissolve capsaicinoid ester and menthol in 100ml soybean oil, and set aside, then dissolve L-carnitine and conjugated linoleic acid in 100ml water, set aside.

实施例4Example 4

本实施例的减肥配方为辣椒素酯100mg;薄荷醇5g;左旋肉碱10g;共轭亚油酸10g。按照配方质量称取各组分,将辣椒素酯和薄荷醇溶于200ml玉米油中,待用,然后将左旋肉碱和共轭亚油酸溶于200ml水中,待用。The weight loss formula of this embodiment is 100 mg of capsaicin ester; 5 g of menthol; 10 g of L-carnitine; and 10 g of conjugated linoleic acid. Weigh each component according to formula quality, dissolve capsaicinoid ester and menthol in 200ml corn oil, stand-by, then dissolve L-carnitine and conjugated linoleic acid in 200ml water, stand-by.

实施例5Example 5

本实施例的减肥配方为辣椒素酯100mg;薄荷醇5g;左旋肉碱10g;共轭亚油酸10g。按照配方质量称取各组分,将辣椒素酯和薄荷醇溶于40ml玉米油中,待用,然后将左旋肉碱和共轭亚油酸溶于40ml水中,待用。The weight loss formula of this embodiment is 100 mg of capsaicin ester; 5 g of menthol; 10 g of L-carnitine; and 10 g of conjugated linoleic acid. Weigh each component according to formula quality, dissolve capsaicinoid ester and menthol in 40ml corn oil, stand-by, then dissolve L-carnitine and conjugated linoleic acid in 40ml water, stand-by.

对比例1Comparative example 1

对比例1与实施例4的区别在于,对比例1的减肥配方为薄荷醇5.1g;左旋肉碱10g;共轭亚油酸10g。The difference between Comparative Example 1 and Example 4 is that the weight loss formula of Comparative Example 1 is 5.1 g of menthol; 10 g of L-carnitine; and 10 g of conjugated linoleic acid.

对比例2Comparative example 2

对比例2与实施例4的区别在于,对比例2的减肥配方为辣椒素酯5.1g;左旋肉碱10g;共轭亚油酸10g。The difference between Comparative Example 2 and Example 4 is that the weight loss formula of Comparative Example 2 is 5.1 g of capsaicinoid; 10 g of L-carnitine; and 10 g of conjugated linoleic acid.

对比例3Comparative example 3

对比例3与实施例4的区别在于,对比例3的减肥配方为辣椒素酯100mg;薄荷醇5g;左旋肉碱20g。The difference between Comparative Example 3 and Example 4 is that the weight loss formula of Comparative Example 3 is 100 mg of capsaicinoid; 5 g of menthol; and 20 g of L-carnitine.

对比例4Comparative example 4

对比例4与实施例4的区别在于,对比例4的减肥配方为辣椒素酯100mg;薄荷醇5g;共轭亚油酸20gThe difference between Comparative Example 4 and Example 4 is that the weight loss formula of Comparative Example 4 is 100 mg of capsaicin ester; 5 g of menthol; 20 g of conjugated linoleic acid

对比例5Comparative example 5

对比例5的减肥配方为辣椒素酯850mg;薄荷醇50mg;左旋肉碱50mg;共轭亚油酸50mg。按照配方质量称取各组分,将辣椒素酯和薄荷醇溶于850ml大豆油中,待用,然后将左旋肉碱和共轭亚油酸溶于850ml水中,待用。The weight-loss formula of Comparative Example 5 was 850 mg of capsaicin ester; 50 mg of menthol; 50 mg of L-carnitine; and 50 mg of conjugated linoleic acid. Weigh each component according to formula quality, dissolve capsaicinoid ester and menthol in 850ml soybean oil, stand-by, then dissolve L-carnitine and conjugated linoleic acid in 850ml water, stand-by.

对上述实施例1-5和对比例1-5进行减肥功能的测定,测定方法如下:本方法以高热量食物诱发动物肥胖,再给予受试样品,观察动物体重、体内脂肪含量的变化。The above-mentioned Examples 1-5 and Comparative Examples 1-5 were used to measure the weight loss function. The measurement method is as follows: In this method, high-calorie food is used to induce obesity in animals, and then the test samples are given to observe the changes in animal body weight and body fat content.

1.实验动物1. Experimental animals

选用体重相近的雄性SD大鼠,每组10只。Male SD rats with similar body weight were selected, 10 in each group.

2.高热量模型饲料2. High-calorie model feed

猪油15%、蔗糖15%、蛋黄粉10%、全脂奶粉1%、混合盐1%、混合维生素0.1%、基础饲料57.9%。15% lard, 15% sucrose, 10% egg yolk powder, 1% whole milk powder, 1% mixed salt, 0.1% mixed vitamins, 57.9% basic feed.

3.实验步骤3. Experimental steps

3.1适应期:170只大鼠于屏障系统下大鼠喂饲维持饲料观察7天。3.1 Adaptation period: 170 rats were fed with maintenance feed under the barrier system and observed for 7 days.

3.2造模期:3.2 Modeling period:

适应期结束后按体重随机分成2组,10只大鼠给予维持饲料作为空白对照组,160只大鼠给予高热量模型饲料。每周记录给食量、撒食量、剩食量,称量体重1次。After the adaptation period, they were randomly divided into two groups according to body weight, 10 rats were given maintenance feed as a blank control group, and 160 rats were given high-calorie model feed. The amount of food given, the amount of sprinkled food, and the amount of leftover food were recorded every week, and the body weight was weighed once.

喂养2周后,给予高热量饲料的160只大鼠按体重增重排序,淘汰体重增重较低的50只肥胖抵抗大鼠。将筛选出的110只肥胖敏感大鼠再给予高热量饲料6周,空白对照组同时给予维持饲料。After feeding for 2 weeks, the 160 rats given high-calorie diet were sorted according to their body weight gain, and 50 obesity-resistant rats with lower body weight gain were eliminated. The 110 obesity-sensitive rats screened out were given high-calorie feed for another 6 weeks, and the blank control group was given maintenance feed at the same time.

3.3受试样品给予:3.3 Test sample administration:

造模期结束后,110只肥胖敏感大鼠按体重随机分成11组,分别为模型对照组、实施例1组、实施例2组、实施例3组、实施例4组、实施例5组、对比例1组、对比例2组、对比例3组、对比例4组、对比例5组。每周记录给食量、撒食量、剩食量,称量体重1次。模型对照组、实施例组和对比例组给予高热量模型饲料,空白对照组给予维持饲料。实施例1组、实施例2组、实施例3组、实施例4组、实施例5组、对比例1组、对比例2组、对比例3组、对比例4组和对比例5组先按2ml/kg大鼠体重将辣椒素酯和薄荷醇溶液灌胃给与大鼠,然后按2ml/kg大鼠体重将左旋肉碱和共轭亚油酸溶液灌胃给与大鼠,模型对照组和空白对照组给予等量的水,受试样品给予时间为6周。After the modeling period ended, 110 obesity-sensitive rats were randomly divided into 11 groups according to body weight, which were respectively model control group, embodiment 1 group, embodiment 2 group, embodiment 3 group, embodiment 4 group, embodiment 5 group, Comparative Example 1 Group, Comparative Example 2 Group, Comparative Example 3 Group, Comparative Example 4 Group, and Comparative Example 5 Group. The amount of food given, the amount of sprinkled food, and the amount of leftover food were recorded every week, and the body weight was weighed once. The model control group, the example group and the comparative example group were given high-calorie model feed, and the blank control group was given maintenance feed. Example 1 group, Example 2 group, Example 3 group, Example 4 group, Example 5 group, Comparative example 1 group, Comparative example 2 group, Comparative example 3 group, Comparative example 4 group and Comparative example 5 groups first Gavage capsaicin ester and menthol solution to rats at 2ml/kg body weight of rats, and then give rats intragastric administration of L-carnitine and conjugated linoleic acid solution at 2ml/kg rat body weight, model control The same amount of water was given to the control group and the blank control group, and the test sample was given for 6 weeks.

试验结束后,称体重,麻醉,解剖取肾周围脂肪、睾丸周围脂肪,并称重,计算脂肪质量。After the experiment, weigh the body weight, anesthetize, dissect the fat around the kidney and the testis, and weigh them to calculate the fat mass.

4.数据处理和结果判定4. Data processing and result determination

采用方差分析加Q检验进行统计。减肥实验结果如表1所示。Analysis of variance plus Q test was used for statistics. The results of the weight loss experiment are shown in Table 1.

表1不同组方对大鼠增重、体脂肪及进食量的影响Table 1 Effects of different formulas on weight gain, body fat and food intake of rats

实施例组的体重增重低于模型对照组,体内脂肪重量低于模型对照组,差异具有显著性,而摄食量不显著低于模型对照组,可判定该受试样品动物减肥功能实验结果阳性。而对比例组虽然体重增重、体内脂肪重量低于模型组,但是数值均高于实施例组,说明缺少四种成分的一种,形成的配方虽然可以轻微控制体重增加,但是其效果却远远不如实施例组。The body weight gain of the embodiment group is lower than that of the model control group, and the body fat weight is lower than that of the model control group. The difference is significant, but the food intake is not significantly lower than that of the model control group. It can be determined that the test sample animal weight loss function test results positive. Although the weight gain and body fat weight of the control group are lower than those of the model group, the values are higher than those of the example group, indicating that one of the four ingredients is missing, and although the formed formula can slightly control the weight gain, its effect is far greater than that of the example group. far less than the example group.

本处实施例对本发明要求保护的技术范围中点值未穷尽之处,同样都在本发明要求保护的范围内。The embodiment here does not exhaust the midpoint value of the technical scope claimed by the present invention, and also falls within the scope of the present invention.

本文中所描述的具体实施例仅仅是对本发明精神作举例说明。本发明所属技术领域的技术人员可以对所描述的具体实施例做各种修改或补充或采用类似的方式替代,但并不会偏离本发明的精神或者超越所附权利要求书所定义的范围。The specific embodiments described herein are merely illustrative of the spirit of the invention. Those skilled in the art to which the present invention pertains can make various modifications or supplements to the described specific embodiments or adopt similar methods to replace them, but they will not deviate from the spirit of the present invention or go beyond the scope defined in the appended claims.

尽管对本发明已作出了详细的说明并引证了一些具体实施例,但是对本领域熟练技术人员来说,只要不离开本发明的精神和范围可作各种变化或修正是显然的。Although the present invention has been described in detail and some specific examples have been cited, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the present invention.

Claims (5)

1. a kind of prescription for losing weight, which is characterized in that the formula includes the following components'mass percentage:Capsiate 0.1~ 80%;Menthol 1~80%;L-cn 1~60%;Conjugated linoleic acid 1~80%.
2. a kind of prescription for losing weight according to claim 1, which is characterized in that the formula includes following mass percent Component:Capsiate 0.1~40%;Menthol 10~50%;L-cn 10~50%;Conjugated linoleic acid 15~55%.
3. a kind of prescription for losing weight according to claim 1, which is characterized in that the formula includes following mass percent Component:Capsiate 0.1~10%;Menthol 15~20%;L-cn 30~40%;Conjugated linoleic acid 30~40%.
4. a kind of prescription for losing weight according to claim 1, which is characterized in that the formula includes following mass percent Component:Capsiate 0.3~0.5%;Menthol 19~20%;L-cn 39~40%;Conjugated linoleic acid 39~40%.
5. a kind of application process of prescription for losing weight as described in claim 1, which is characterized in that the application process is:According to Prescription quality percentage weighs each component, and capsiate and menthol are dissolved in oil-based solvent, is applied to life entity, then will L-cn and conjugated linoleic acid are soluble in water, continue to be applied to life entity.
CN201810213630.5A 2018-03-15 2018-03-15 A kind of prescription for losing weight and its application process Pending CN108272903A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810213630.5A CN108272903A (en) 2018-03-15 2018-03-15 A kind of prescription for losing weight and its application process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810213630.5A CN108272903A (en) 2018-03-15 2018-03-15 A kind of prescription for losing weight and its application process

Publications (1)

Publication Number Publication Date
CN108272903A true CN108272903A (en) 2018-07-13

Family

ID=62809773

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810213630.5A Pending CN108272903A (en) 2018-03-15 2018-03-15 A kind of prescription for losing weight and its application process

Country Status (1)

Country Link
CN (1) CN108272903A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023048060A1 (en) * 2021-09-21 2023-03-30 株式会社片岡製作所 Screening method using brown adipocytes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927223A (en) * 2006-09-11 2007-03-14 苟春虎 Fat-reducing and beauty nourishing capsule
CN101401874A (en) * 2008-11-07 2009-04-08 天津农学院 Lozenge for refreshing oneself and preparation method thereof
CN104586669A (en) * 2013-10-31 2015-05-06 广州熹美生物科技有限公司 Fat-reducing externally-applied cream
CN106604725A (en) * 2014-07-03 2017-04-26 Nan全球有限责任公司 Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing development of diabetes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1927223A (en) * 2006-09-11 2007-03-14 苟春虎 Fat-reducing and beauty nourishing capsule
CN101401874A (en) * 2008-11-07 2009-04-08 天津农学院 Lozenge for refreshing oneself and preparation method thereof
CN104586669A (en) * 2013-10-31 2015-05-06 广州熹美生物科技有限公司 Fat-reducing externally-applied cream
CN106604725A (en) * 2014-07-03 2017-04-26 Nan全球有限责任公司 Methods and compositions for treating obesity, preventing weight gain, promoting weight loss, promoting slimming, or treating or preventing development of diabetes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
夏文品: "辣椒素酯和磷脂酰乙醇胺的合成研究", 《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》 *
朱五红: "《女人养气补血饮食宜忌全书》", 30 June 2014, 中国妇女出版社 *
梁淑明: "共轭亚油酸减肥与降血脂药理作用及体内脂肪酸组成分析", 《万方数据知识服务平台》 *
熊双丽: "功能性食品的发展及研究新动向 ", 《安徽农业科学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023048060A1 (en) * 2021-09-21 2023-03-30 株式会社片岡製作所 Screening method using brown adipocytes

Similar Documents

Publication Publication Date Title
CN103330055B (en) Feed for regulating and controlling color of yolk of egg and cholesterol and production method of feed
EP2114174A2 (en) Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
JP2009167195A (en) Agent against stress-induced disease
Hewlings et al. Sulfur in human health
CN110521871A (en) It is a kind of alleviate acute and chronic stress to pet injure nutritional preparation and its application
CN106343218A (en) Vitamin and amino acid nutritive liquid for pets and preparation method thereof
US20220240558A1 (en) High-energy food supplement based on inverted sugars and ergogenic products for use in physical activity and method for producing same
US20210353578A1 (en) Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
CN103211121A (en) Method for relieving heat stress of black-bone chicken
CN107440102A (en) A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof
CN105407899B (en) Composition for therapeutic advance kidney trouble
JP2000309530A (en) Brown fat increasing agent comprising conjugated linoleic acid as active ingredient
JP6538043B2 (en) Methods and compositions for improving renal function
JP2007045814A (en) Cholesterol regulating agent
WO2015137387A1 (en) Muscle enhancing drug
CN105685519A (en) Goose feed with folium mori powder
CN108272903A (en) A kind of prescription for losing weight and its application process
RU2390271C1 (en) Preparation for increasing of organism adaptability to extreme conditions
JP2009107987A (en) Muscle enhancer
CN110584120A (en) Bone health composition
WO2010078659A1 (en) Compositions and methods for nutritional prevention and treatment of alzheimer's-associated conditions
JP2010105946A (en) Muscle protein enhancer and drug or food containing the same
WO2018039297A1 (en) Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
JPS60186261A (en) Solid food composition
CN113491334B (en) nutritional composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination